Cortagen (Ala-Glu-Asp-Pro) represents a critical synthetic tetrapeptide utilized in preclinical gerontological research to decipher nuclear gene regulation and chromatin restructuring. PX1 Research provides high-purity, US-manufactured Cortagen backed by lot-specific analytical documentation for qualified laboratory evaluation.
Cortagen (Ala-Glu-Asp-Pro) represents a critical synthetic tetrapeptide utilized in preclinical gerontological research to decipher nuclear gene regulation and chromatin restructuring. PX1 Research provides high-purity, US-manufactured Cortagen backed by lot-specific analytical documentation for qualified laboratory evaluation.
A reliable aging mechanism revelation Cortagen supplier delivers verified Ala-Glu-Asp-Pro (AEDP) tetrapeptide meeting strict purity standards (>98% by HPLC/MS) with comprehensive lot-specific Certificates of Analysis. Research indicates Cortagen modulates epigenetic mechanisms by interacting with chromatin, regulating gene expression, and reducing age-associated transcriptional noise in preclinical cellular models.
In experimental biology, Cortagen serves as a tool for probing nuclear peptide-DNA interactions. By examining how this short synthetic sequence binds specific promoter regions, investigators can map fundamental pathways involved in cellular senescence, transcriptomic stability, and organ-specific tissue degeneration.
The scientific investigation of bioregulatory peptides has revealed that short amino acid sequences can penetrate nuclear membranes and directly bind to the major and minor grooves of DNA. Cortagen, composed of the specific tetrapeptide sequence L-alanyl-L-glutamyl-L-aspartyl-L-proline (Ala-Glu-Asp-Pro), has demonstrated selective affinity for heterochromatin structures in preclinical models.
In vitro nuclear binding assays demonstrate that Cortagen induces structural decondensation of silenced heterochromatin regions. This structural shift allows transcription factors and RNA polymerase II access to promoter sequences associated with cellular repair enzymes, antioxidant defenses, and structural protein synthesis.
This epigenetic remodeling mechanism provides key insights into how short peptides counter the transcriptional drift typically observed during cellular senescence. Rather than acting through classical membrane-bound receptor signaling cascades, Cortagen’s primary mechanism of action relies on direct genomic interaction, establishing it as a core standard in epigenetic peptide mechanisms literature.
Preclinical gerontological studies utilizing rodent models of accelerated aging have documented broad transcriptomic shifts upon exposure to Cortagen. Researchers observing age-associated biomarkers have noted reductions in pro-inflammatory cytokine expression (such as IL-6, TNF-alpha, and NF-kB signaling cascades) within central nervous system tissues and peripheral organs.
In vitro cell culture models using senescent human fibroblast lines indicate that Cortagen application correlates with improved DNA double-strand break repair capacity. Quantitative PCR and Western blot analyses show up-regulated expression of key repair machinery, including Ku70, Ku80, and ATM kinase pathways, following treatment with research-grade Cortagen.
Furthermore, non-human primate and rodent tissue assays demonstrate enhanced mitochondrial function and reduced reactive oxygen species (ROS) accumulation. These observations suggest that Cortagen helps maintain mitochondrial membrane potential under oxidative stress conditions, mitigating secondary genomic damage caused by metabolic byproduct accumulation.
While Cortagen exhibits general cellular repair modulation, its primary focus in historical biogerontology has centered on central nervous system (CNS) tissue resilience. In preclinical models of cerebral ischemia and neurodegeneration, Cortagen administration demonstrated protective effects on neuronal survival and synaptic integrity.
Experimental assays evaluating nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) expression indicate that Cortagen upregulates these neurotrophins at the transcriptional level. Murine models of ischemic brain injury showed reduced infarct volumes and decreased caspase-3 apoptotic signaling when treated with research-grade Cortagen prior to or immediately following ischemic insult.
Laboratory researchers utilizing Cortagen alongside other neuro-active compounds often evaluate its comparative efficacy against pinealon, another central nervous system short peptide, to establish tissue-specific gene expression maps across different brain regions, including the cortex, hippocampus, and cerebellum.
To understand Cortagen’s unique position in peptide science, researchers frequently compare its structure, sequence length, and target organ specificity against other prominent short-chain bioregulators in gerontological research.
While epitalon (Ala-Glu-Asp-Gly) targets telomerase activation and pineal gland regulation, and vilon (Lys-Glu) primarily modulates immune function and thymic involution, Cortagen (Ala-Glu-Asp-Pro) exhibits specific activity toward central nervous system gene expression and profound chromatin decondensation in senescent cells. Comparative studies across these compounds allow investigators to map how subtle single-amino-acid variations alter peptide-DNA binding kinetics and downstream gene transcription.
The following matrix outlines the fundamental distinctions among these core bioregulatory research compounds:
Conducting reproducible biogerontological experiments requires research-grade Cortagen manufactured under stringent quality control protocols. Because minor impurities, residual solvents, or synthesis truncated sequences can distort gene expression profiling and cell viability assays, rigorous supplier verification is essential.
PX1 Research maintains an unyielding focus on analytical precision. Every lot of cortagen undergoes thorough verification, ensuring researchers receive compounds that meet defined physical and chemical parameters:
1. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC): Establishes chemical purity exceeding 98.0%, confirming the absence of peptide fragments or structural isomers. 2. Electrospray Ionization Mass Spectrometry (ESI-MS): Confirms exact molecular weight and amino acid sequence fidelity corresponding to the theoretical mass of Ala-Glu-Asp-Pro. 3. Endotoxin Testing (LAL Assay): Verifies bacterial endotoxin levels remain strictly below <0.01 EU/mg, preventing unspecific immune or inflammatory reactions in cell culture and tissue models. 4. Microscopic and Solubility Profiling: Ensures consistent lyophilized cake structure and rapid solubilization in standard aqueous buffers.
Proper handling and storage of Cortagen are vital to preserve sequence integrity and prevent hydrolytic degradation or oxidation. Cortagen is supplied as a sterile, lyophilized (freeze-dried) powder in sealed laboratory vials.
For reconstitution, investigators should use sterile Bacteriostatic Water, Phosphate-Buffered Saline (PBS, pH 7.4), or Sterile Water for Injection, depending on the requirements of the specific in vitro assay or preclinical model. The reconstitution vector should be introduced gently down the inner glass wall of the vial, followed by mild swirling. Mechanical agitation or vigorous vortexing must be avoided, as shear forces can disrupt peptide stability.
Lyophilized Cortagen should be stored at -20°C for short-term projects or -80°C for long-term storage, protected from light and moisture. Following reconstitution, liquid aliquots should be frozen at -80°C to minimize freeze-thaw cycles, which accelerate peptide chain cleavage and drop biological activity over time. Additional guidance on laboratory peptide management can be found in our research library.
Acquiring high-purity peptides for advanced genetic and biogerontological assays requires absolute transparency from the supplier. PX1 Research manufactures all research compounds within USA-based, GMP-compliant facilities adhering to ISO 17025 laboratory accreditation standards.
Unlike unverified foreign import channels, PX1 Research subjects every batch to independent third-party testing in accredited US laboratories. Every shipment includes a lot-traceable Certificate of Analysis (COA) detailing HPLC chromatograms, mass spectra, and quantitative endotoxin levels. This commitment ensures that research teams receive pure, reproducible reagents for high-impact publication work.
Institutional laboratories, academic departments, and corporate research organizations seeking bulk quantities or recurring supply contracts can coordinate procurement through our dedicated wholesale portal to secure bulk-tier lot reservations and guaranteed lot consistency.
As high-throughput single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics advance, the role of Cortagen and related bioregulators in unraveling aging mechanisms continues to expand. Current investigations focus on mapping cell-type-specific responses to Cortagen exposure within heterogeneous tissue environments.
Key areas of active preclinical inquiry include quantifying Cortagen’s effect on histone acetylation marks (such as H3K9ac and H3K27ac), measuring chromatin accessibility changes via ATAC-seq, and determining whether short peptide intervention can reset epigenetic clocks in aging cellular populations. Explore our complete catalog of all-peptides to support comprehensive multi-compound research designs.
What is Cortagen and what is its molecular structure?
Cortagen is a synthetic bioregulatory tetrapeptide with the amino acid sequence L-alanyl-L-glutamyl-L-aspartyl-L-proline (Ala-Glu-Asp-Pro). It is synthesized for laboratory research to investigate gene regulation, chromatin structure, and aging mechanisms in cellular and animal models.
What is the primary mechanism of Cortagen in preclinical aging studies?
Preclinical data suggest Cortagen acts via direct epigenetic modulation. It penetrates the nuclear envelope to bind chromatin structures, decondensing heterochromatin and altering the transcription rates of genes involved in DNA repair, anti-inflammatory pathways, and oxidative stress response.
How does Cortagen differ from Epitalon?
While both are short bioregulatory peptides investigated in gerontology, Cortagen (Ala-Glu-Asp-Pro) focuses heavily on central nervous system gene expression, neuroprotection, and chromatin restructuring. Epitalon (Ala-Glu-Asp-Gly) is predominantly studied for telomerase activation and pineal-hypophyseal regulation.
What analytical tests verify PX1 Research Cortagen quality?
Every lot of Cortagen from PX1 Research undergoes third-party verification via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for purity (>98%), Electrospray Ionization Mass Spectrometry (ESI-MS) for sequence confirmation, and Limulus Amebocyte Lysate (LAL) testing for endotoxin levels (<0.01 EU/mg).
How should Cortagen be stored upon receipt in the laboratory?
Lyophilized Cortagen powder should be stored at -20°C for short-term storage or -80°C for extended stability, protected from light. Reconstituted solution aliquots should be stored at -80°C to avoid repeated freeze-thaw degradation.
What solvent is recommended for reconstituting Cortagen in cell assays?
Cortagen is readily soluble in standard laboratory aqueous solvents, including sterile Phosphate-Buffered Saline (PBS, pH 7.4), Bacteriostatic Water, or Sterile Water for Injection. The choice depends on the specific in vitro or in vivo experimental assay parameters.
Are PX1 Research compounds manufactured in the USA?
Yes. All PX1 Research peptides are manufactured in USA-based, GMP-compliant facilities and tested in ISO 17025 accredited laboratories to ensure absolute quality control and batch consistency.
Can Cortagen be ordered in bulk for institutional research projects?
Yes, accredited academic laboratories, biotechnology organizations, and institutional researchers can request bulk lot reserves and specialized packaging options via the PX1 Research wholesale division.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.